WHO Pandemic Talks Advance, but Pathogen-Sharing Deal Is Unfinished
WHO member states streamlined pandemic pathogen-sharing language in July but left key rules unresolved, delaying the agreement’s signature and ratification phase.
WHO member states made progress on rules for sharing dangerous pathogens and genetic sequence data during two weeks of negotiations in Geneva, but they did not finalize the annex needed to move the global Pandemic Agreement toward signature and ratification.
The seventh meeting of the Intergovernmental Working Group ran from July 6 through July 17, 2026. In a July 20 update, the World Health Organization said countries streamlined parts of the draft Pathogen Access and Benefit Sharing, or PABS, annex while continuing discussions on several politically and technically difficult issues.
What the July talks changed
The proposed system is designed to encourage countries and laboratories to share pathogen materials and genetic sequence information quickly during a potential pandemic. In return, the framework would connect that sharing to fair access to benefits developed from the information, including vaccines, diagnostics and therapeutics.
WHO said negotiations focused on the contracts that would support the system, the structure of laboratory networks handling pathogen materials and sequence information, recognized sequence databases, and how benefits should be defined and distributed.
Those details matter because they would help determine who can access shared materials, what participating manufacturers would be expected to provide, and how quickly countries could use scientific information during a health emergency. The practical effects, however, depend on the final text, later adoption and implementation, and participation by manufacturers and other institutions.
Why the broader agreement is still pending
The World Health Assembly adopted the WHO Pandemic Agreement on May 20, 2025, but the agreement’s process is not complete. The PABS annex remains a required part of the package. WHO’s explanation of the process says the agreement can open for signature only after the annex is adopted by the Health Assembly.
That means the July outcome was progress in negotiations, not approval or completion of the agreement. A PABS document issued before the July session remains a draft negotiating text rather than an adopted legal instrument.
The WHO Secretariat is facilitating and reporting on the process, but member states—not WHO officials acting independently—are negotiating and deciding the text.
What happens next
The next scheduled negotiating session is set for September 14 through September 18, 2026. That meeting is not a guaranteed deadline for completion. The outcome is expected to go to the Eightieth World Health Assembly in May 2027, or earlier if a special Health Assembly session is convened in 2026.
For the public, there is no immediate change to vaccine access, national pandemic rules or emergency health procedures from the July meeting alone. The significance is procedural but consequential: countries are still trying to settle the terms of a future bargain in which faster sharing of pathogen information is tied to clearer and more equitable access to the products developed from it.
Sources
Discover more from Interactive News
Subscribe to get the latest posts sent to your email.
